Metabolomic and lipidomic signatures associated with activation of human cDC1 (BDCA3


Journal

Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672

Informations de publication

Date de publication:
01 2022
Historique:
revised: 17 06 2021
received: 07 01 2021
accepted: 06 07 2021
pubmed: 26 8 2021
medline: 22 2 2022
entrez: 25 8 2021
Statut: ppublish

Résumé

Dendritic cells (DCs) bridge the connection between innate and adaptive immunity. DCs present antigens to T cells and stimulate potent cytotoxic T-cell responses. Metabolic reprogramming is critical for DC development and activation; however, metabolic adaptations and regulation in DC subsets remains largely uncharacterized. Here, we mapped metabolomic and lipidomic signatures associated with the activation phenotype of human conventional DC type 1, a DC subset specialized in cross-presentation and therefore of major importance for the stimulation of CD8

Identifiants

pubmed: 34431087
doi: 10.1111/imm.13409
pmc: PMC9426619
doi:

Substances chimiques

Amino Acids 0
Biomarkers 0
Cytokines 0
Lipopolysaccharide Receptors 0
THBD protein, human 0
Thrombomodulin 0
Toll-Like Receptors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

99-109

Informations de copyright

© 2021 The Authors. Immunology published by John Wiley & Sons Ltd.

Références

Gastroenterology. 2013 Feb;144(2):414-425.e7
pubmed: 23089201
Immunology. 2005 Aug;115(4):473-83
pubmed: 16011516
Sci Immunol. 2017 Jul 7;2(13):
pubmed: 28783704
Trends Immunol. 2019 Dec;40(12):1163-1179
pubmed: 31732284
Mol Carcinog. 2016 Oct;55(10):1411-23
pubmed: 26310886
Nat Microbiol. 2016 Oct 17;2:16191
pubmed: 27748732
Hepatology. 2013 May;57(5):1705-15
pubmed: 23213063
Arch Biochem Biophys. 2018 Oct 1;655:1-11
pubmed: 30077544
J Immunol. 2010 Sep 15;185(6):3313-25
pubmed: 20702727
Clin Cancer Res. 2016 May 1;22(9):2155-66
pubmed: 26712687
J Exp Med. 2012 Apr 9;209(4):653-60
pubmed: 22430490
Nat Methods. 2015 Jun;12(6):523-6
pubmed: 25938372
Atherosclerosis. 2021 Jan;316:1-7
pubmed: 33260006
Front Immunol. 2018 Nov 01;9:2489
pubmed: 30455688
Methods Mol Biol. 2016;1390:273-85
pubmed: 26803635
Blood. 2012 Aug 16;120(7):1422-31
pubmed: 22786879
Cancer Res. 2013 Feb 1;73(3):1063-75
pubmed: 23345163
Structure. 2011 Apr 13;19(4):447-59
pubmed: 21481769
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Aug 5;793(1):141-50
pubmed: 12880861
Metabolites. 2019 Mar 22;9(3):
pubmed: 30909447
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):961-7
pubmed: 20064485
J Exp Med. 2010 Jun 7;207(6):1261-71
pubmed: 20479117
J Immunol. 2000 Dec 1;165(11):6037-46
pubmed: 11086035
Nature. 2018 Jun;558(7708):141-145
pubmed: 29849151
Immunity. 2006 Jul;25(1):153-62
pubmed: 16860764
J Exp Med. 2010 Jun 7;207(6):1247-60
pubmed: 20479116
J Biol Chem. 2007 Mar 9;282(10):7576-81
pubmed: 17204473
Dev Cell. 2017 Jul 10;42(1):9-21.e5
pubmed: 28697336
Anal Chim Acta. 2017 Aug 8;980:1-24
pubmed: 28622799
J Mol Cell Biol. 2020 Jul 1;12(7):543-555
pubmed: 31900478
Nat Immunol. 2014 Apr;15(4):323-32
pubmed: 24562310
Immunity. 2012 Jul 27;37(1):60-73
pubmed: 22795876
Immunol Cell Biol. 2018 Apr;96(4):390-400
pubmed: 29344995
Blood. 2012 Dec 20;120(26):5163-72
pubmed: 23093620
Annu Rev Immunol. 2000;18:767-811
pubmed: 10837075
J Immunol. 2006 Nov 15;177(10):6695-704
pubmed: 17082582
F1000Res. 2017 Apr 10;6:456
pubmed: 28580131
Front Immunol. 2018 Feb 05;9:141
pubmed: 29459863
Biomedicines. 2015 Dec 02;3(4):282-303
pubmed: 28536413
J Immunol Res. 2015;2015:743169
pubmed: 26229971
Front Immunol. 2019 Apr 25;10:775
pubmed: 31073300
Sci Rep. 2016 Sep 22;6:33900
pubmed: 27652524
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
Nat Med. 2010 Aug;16(8):856-8
pubmed: 20689547
Immunology. 2022 Jan;165(1):99-109
pubmed: 34431087
Blood. 2013 Jun 20;121(25):5034-44
pubmed: 23482932
Nat Commun. 2020 Aug 14;11(1):4107
pubmed: 32796836
Genome Biol. 2008 Jan 24;9(1):R17
pubmed: 18218067
J Exp Med. 2012 May 7;209(5):935-45
pubmed: 22547651
FEBS Lett. 2019 Jan;593(2):195-208
pubmed: 30431159

Auteurs

Farhan Basit (F)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.

Tom van Oorschot (T)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.

Jessie van Buggenum (J)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.

Rico J E Derks (RJE)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Sarantos Kostidis (S)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

Martin Giera (M)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.

I Jolanda M de Vries (IJM)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands.
Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH